Cargando…
Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series
BACKGROUND: Children with rheumatic diseases (cRD) receiving immunosuppressive medications (IM) are at a higher risk for acquiring potentially lethal pathogens, including Histoplasma capsulatum (histoplasmosis), a fungal infection that can lead to prolonged hospitalization, organ damage, and death....
Autores principales: | Brown, Rachel A., Barbar-Smiley, Fatima, Yildirim-Toruner, Cagri, Ardura, Monica I., Ardoin, Stacy P., Akoghlanian, Shoghik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185916/ https://www.ncbi.nlm.nih.gov/pubmed/34098976 http://dx.doi.org/10.1186/s12969-021-00581-7 |
Ejemplares similares
-
Increasing access to psychological services within pediatric rheumatology care
por: Goldstein-Leever, Alana, et al.
Publicado: (2023) -
Exploring Pediatric Tele-Rheumatology Practices During COVID-19: A Survey of the PRCOIN Network
por: Goh, Y. Ingrid, et al.
Publicado: (2021) -
Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreat
por: Yildirim-Toruner, Cagri, et al.
Publicado: (2022) -
Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis
por: Gagne, Samuel, et al.
Publicado: (2023) -
Quantitative evaluation of a pediatric rheumatology transition program
por: Jensen, Paul T., et al.
Publicado: (2015)